Charles C. Duncan's most recent trade in Vanda Pharmaceuticals Inc was a trade of 41,600 Common Stock done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharma Inc | Charles C. Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 41,600 | 98,701 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharma Inc | Charles C. Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2026 | 57,101 | 57,101 (0%) | 0% | 0 | Common Stock |